Stocks · Health care · Biological Products, (No Diagnostic Substances)

Allogene Therapeutics, Inc.

ALLO Clue Score24
United States Fiscal year ends December CIK 0001737287 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Arie Belldegrun
24 May 2021
Director
Exercised, kept
379,066
$18.22
$6.91M
Eric Thomas Schmidt
24 May 2021
Chief Financial Officer
Exercised, kept
14,897
$18.22
$271.42K
David D Chang
24 May 2021
President and CEO
Exercised, kept
27,410
$18.22
$499.41K
Veer Bhavnagri
17 Dec 2020
General Counsel
Exercised, kept
51,500
$2.27
$116.91K
Alison Moore
13 Aug 2020
Chief Technical Officer
Exercised, kept
32,451
$2.27
$73.66K
Alison Moore
28 Jun 2019
Chief Technical Officer
Exercised, kept
27,816
$2.27
$63.14K

What was left out

Form 4 filings counted 244
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 32
Sales at will 98
Transactions with no price 0
Shares from compensation/vesting 102,298,948
Sales filed before the plan box existed 70
History held since 17 Oct 2018